Lucid Diagnostics LUCD Institutional Ownership

Updated Oct 11, 2026

Lucid Diagnostics Inc. (NASDAQ:LUCD) had 113 institutional holders reporting a position on Form 13F for the quarter ended June 30, 2026.

• These investors held 32.15% of Lucid Diagnostics' outstanding shares at the end of Q2 2026, up from 21.59% in Q1 2026.
• Total holdings of LUCD shares rose 72.27% from Q1 2026, and the holder count rose 59.15% from Q2 2025.
• Looking at the 113 holders of LUCD individually, 81 added to their positions, 13 reduced their stakes and 19 left their positions unchanged.
• In total, institutional investors held 61.33Mn shares of Lucid Diagnostics at the end of Q2 2026, up 25.73Mn from the prior quarter and up 42.84Mn from a year earlier.
• Alyeska Investment Group, L.P. led 13F holders of LUCD with 8.86Mn shares as of June 30, 2026, or 4.64% of shares outstanding.
• The largest position increases in LUCD for Q2 2026 were by BlackRock, Inc. (+3.73Mn shares), Two Seas Capital LP (+3Mn shares), Vanguard Capital Management LLC (+2.4Mn shares), First Manhattan Co. LLC (+1.87Mn shares) and Geode Capital Management, LLC (+1.54Mn shares).
• The largest position reductions in LUCD for Q2 2026 were by Renaissance Technologies LLC (-428.36K shares), Goldman Sachs Group Inc (-172.05K shares), FMR LLC (-116.35K shares), Susquehanna International Group, LLP (-87.06K shares) and LPL Financial LLC (-39.22K shares).
• Business Quant data shows the 10 biggest positions in Lucid Diagnostics as of Q2 2026 were held by Alyeska Investment Group, L.P. (8.86Mn shares), BlackRock, Inc. (8.37Mn shares), Vanguard Capital Management LLC (6.56Mn shares), Two Seas Capital LP (6Mn shares), Masters Capital Management LLC (4Mn shares), Aberdeen Group plc (3.82Mn shares), Geode Capital Management, LLC (3.79Mn shares), State Street Corp (2.44Mn shares), First Manhattan Co. LLC (2.19Mn shares) and Wells Fargo & Company (2.07Mn shares).